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Critical roles for murine Reck in the 
regulation of vascular patterning 
and stabilization
Glícia Maria de Almeida*, Mako Yamamoto*†, Yoko Morioka, Shuichiro Ogawa, 
Tomoko Matsuzaki & Makoto Noda
Extracellular matrix (ECM) is known to play several important roles in vascular development, 
although the molecular mechanisms behind these remain largely unknown. RECK, a tumor suppressor 
downregulated in a wide variety of cancers, encodes a membrane-anchored matrix-metalloproteinase-
regulator. Mice lacking functional Reck die in utero, demonstrating its importance for mammalian 
embryogenesis; however, the underlying causes of mid-gestation lethality remain unclear. Using 
Reck conditional knockout mice, we have now demonstrated that the lack of Reck in vascular mural 
cells is largely responsible for mid-gestation lethality. Experiments using cultured aortic explants 
further revealed that Reck is essential for at least two events in sprouting angiogenesis; (1) correct 
association of mural and endothelial tip cells to the microvessels and (2) maintenance of fibronectin 
matrix surrounding the vessels. These findings demonstrate the importance of appropriate cell-cell 
interactions and ECM maintenance for angiogenesis and the involvement of Reck as a critical regulator 
of these events.
Correct vascular development is crucial for all aspects of tissue growth and physiology in vertebrates. In mam-
mals, two families of cytokines; vascular endothelial growth factors (VEGFs) and angiopoietins, are known to 
play a lead role in angiogenesis1–5. Early events during sprouting angiogenesis involve specialization of activated 
endothelial cells into two distinct subtypes: namely, tip and stalk cells. VEGF stimulates the expression of tip cell 
markers, including Flk1 and Notch-ligands of which the Notch-ligands stimulate Notch-signaling in adjacent cells 
to suppress their tip cell phenotype (lateral inhibition) and induce the phenotype of lumen-forming stalk cells6. For 
vascular stabilization, endothelial tubes need to recruit, and be tightly associated with, mural cells (i. e., vascular 
smooth muscle cells and pericytes), whilst platelet-derived growth factor (PDGF) serves as a key attractant in this 
process7. This cell-cell interaction triggers the perivascular deposition of extracellular matrix (ECM) components, 
such as fibronectin (FN) and vascular basement membrane (vBM) to promote vessel maturation and stabilization8,9. 
Matrix metalloproteinases (MMPs) are also known to play major roles in the ECM-remodeling associated with 
angiogenesis10,11, although how this process is regulated remains to be elucidated.
RECK, conserved as a single gene from insects to primates, encodes a membrane-anchored regulator of multiple 
metalloproteinases, including several members of the MMP family12–18. In mammalian cells, RECK expression 
is downregulated by various external stimuli, such as growth factors, low cell density, and low oxygen19–21. RECK 
expression is also downregulated frequently in cancer cells, and restoration of RECK expression in such cells 
results in suppression of tumor angiogenesis, invasion, and metastasis in xenograft models14,17. Recent evidence 
indicates that several oncogenic microRNAs target RECK mRNA20,22–26, strengthening the notion that RECK is a 
tumor suppressor that is downregulated via various mechanisms during carcinogenesis.
Previous studies have also revealed the critical functions of Reck in mammalian development. Mice lacking 
Reck-expression die in utero around embryonic day 10.5 (E10.5), exhibiting reduced tissue integrity, arrested 
vasculogenesis13, and precocious neuronal differentiation13,16. A mouse mutant with reduced Reck-expression 
(ReckLow/∆, see below) demonstrates defects in limb patterning; a phenotype that can be explained by impaired 
Wnt7a-signalling due to tissue damage in limb-bud mesenchyme and overlaying dorsal epithelium21. In some 
rapidly proliferating tissues, such as embryos and uterine implantation chambers, Reck expression is abundant in 
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both vascular endothelial cells and mural cells27. Dilated vessels with abnormal luminal shapes can be observed in 
these tissues in mice with reduced Reck expression. Abundant Reck-expression has also been found in fibroblastic 
cells associated with bifurcating vessels, leading to the speculation that Reck may play a role in non-sprouting 
angiogenesis (e.g., intussusception and pruning)27.
In the present study, we dissected the roles for Reck in different vascular cell types during angiogenesis by using 
multiple lines of newly developed Reck mutant mice. We also employed aortic ring assay (ARA)28,29 to assess the 
ability of aortic tissue explants to form small vessels (microvessels) in vitro. We found that selective inactivation 
of Reck in vascular mural cells caused embryonic death around E10.5 with vascular defects, suggesting that the 
mid-gestation lethality of Reck-null mice can be attributed to the absence of Reck in mural cells. In addition, we 
unexpectedly found that impaired Reck function leads to excessive sprouting of unstable microvessels in vitro, 
raising the possibility that the abnormal, dilated vessels found in Reck-deficient mice may arise by lateral fusion 
of unstable vessels rather than, or in addition to, abortive intussusception.
Results
Cell type-selective inactivation of Reck in vivo. The engineered Reck alleles in mice used in this study 
are listed in Fig. 1a: (1) Reck-, the original null-allele13, (2) ReckCrER, expressing the tamoxifen-regulatable Cre 
recombinase CreERT2 from the Reck locus (Matsuzaki et al. in preparation); (3) ReckE1fx, containing two lox-P sites 
flanking exon-1; (4) Reck∆, a novel null-allele lacking proximal promoter plus exon-1; and (5) ReckLow, a hypomor-
phic allele expressing Reck at ~50% of the wild type (wt) level21. In addition, we utilized two Cre transgenic lines, 
Sm22-Cre30 and Tie2-Cre31, to induce loxP-recombination selectively in mural and endothelial cells, respectively.
Visualization of Reck-positive cells in the yolk sac at embryonic day 10.5 (E10.5), using mice carrying the 
ReckCrER allele together with the mTmG reporter system32, revealed that the majority of Reck-mG cells (green; 
Fig. 1b-1) exhibit cobble stone-like alignment resembling that of Sm22-mG vascular mural cells (green, Fig. 1b-2). 
This phenotype was widespread, rather than the dendritic pattern of Tie2-mG vascular endothelial cells (green, 
Fig. 1b-3), although some cells with ambiguous morphology were also observed (e.g, Fig. 1b-1, arrowhead).
First, to assess the contribution of mural Reck to vascular development, Reck was inactivated using the Sm22-Cre 
driver mouse (Supplementary Fig. S1a,b). The resulting mutant mice, termed Reck cKO (Sm), were reminiscent of 
Reck−/− mice13,27 in that they died around E10.5 (Fig. 1c, triangles) with smaller body size (Fig. 1d-4), poor vascu-
larization in the neural tube (Fig. 1d-5), and dilated perineural vasculature with peculiar luminal shape (Fig. 1d-6). 
As reported previously, Reck−/− embryos displayed reduced tissue integrity (Fig. 1e-7) with frequent breakage of 
the neural tube (e.g., Fig. 1e-8, arrowhead)2. Although Reck cKO (Sm) embryos were not as fragile (Fig. 1e-4), they 
shared some phenotypes with Reck−/− mice such as frequent breakage of dorsal aorta (Fig. 1e-5) and pericardial 
membrane (Fig. 1e-6). Hence, the mid-gestation lethality of Reck-null mice13 may largely be attributable to the 
Reck-deficiency in mural cells.
Next, to assess the contribution of endothelial Reck, Reck was inactivated using the Tie2-Cre mouse 
(Supplementary Fig. S1c,d). Although the mutant mice, termed Reck cKO (Tie), survived beyond E10.5, they died 
before birth (Fig. 1c, squares) and exhibited intra-cranial hemorrhage (Fig. 1f-2; Fig. 1g, panels 6–8) with severe 
abnormalities in vasculature and cytoarchitecture in their cerebral cortex (Fig. 1g, panels 7–10). Hence, Reck in 
Tie2-positive cells is indispensable for later-stage embryogenesis, particularly within the brain.
Effects of Reck-deficiency on microvessel formation. To understand the roles of Reck at the cellular 
level, ARAs28,29 were utilized, which allowed assessment of the ability of dorsal aorta tissue pieces (aortic rings) to 
form microvessels in vitro. Aortae from 5-weeks old, tamoxifen-induced Reck knockout (Reck cKO) and control 
(Cont) mice carrying the mTmG reporter were used. Under optimized conditions (Supplementary Figs S2 and S3a), 
control aortic rings showed a slow but steady increase in microvessel number over the time course observed (Fig. 2a, 
blue line), whereas Reck cKO samples showed an initial rapid increase (up to day 10) followed by a decline (from 
day 12) in the number of microvessels (Fig. 2a, red line). This decline was accompanied by aggregation and thick-
ening of microvessels (Fig. 2b-8, 9, arrowheads; Supplementary Fig. S3b,c). Morphometry of fluorescent images 
(Fig. 2c-f and Supplementary Fig. S4) indicated that the Reck cKO microvessels were wider (Fig. 2c) and covered a 
broader area (Fig. 2d) with lower lacunarity (Fig. 2e). In addition, Reck cKO aortic rings were often accompanied 
by peri-aortic halos, indicating increased local lysis of collagen gel33 (Fig. 2b-10, arrow; Fig. 2f). Thus, Reck– 
deficiency leads to the formation of an excessive number of unstable microvessels in this assay.
Identity of Reck-mG cells. To determine how Reck-deficiency leads to such microvessel phenotypes, the 
nature of Reck-mG cells in ARA was examined. In control cultures, some Reck-mG cells localize at microvessel 
tips (Fig. 3a-1, arrowhead), whilst others are associated with microvessel stalks (Fig. 3a-1, arrow). The former 
look similar to the Tie2-mG or CD31-positive endothelial cells (Fig. 3a-2, arrowhead; Supplementary Fig. S5a, 
magenta) and the latter the Sm22-mG-positive mural cells (Fig. 3a-3, arrow; Supplementary Fig. S5a, green). 
Immunofluorescent staining for another mural marker, α SMA, often detected Reck-mG/α SMA double-positive 
(i.e., mural Reck-mG) cells surrounding microvessel stalks (Fig. 3b-3 and Supplementary Fig. S6-3, white signals 
as indicated by arrows); CD31-staining detected Reck-mG/CD31 double-positive (endothelial Reck-mG) cells 
near microvessel tips (Fig. 3b-9 and Supplementary Fig. S6-9, white signals as indicated by arrowheads) along 
with Reck-mG single-positive (non-endothelial Reck-mG) cells surrounding microvessel stalks (Fig. 3b-9 and 
Supplementary Fig. S6-9, green signals). Reck-mG cells found near microvessel tips were often positive for a 
vascular tip cell marker, Flk1 (Fig. 3c-2, magenta). These results, together with morphometric data (Fig. 3d, e), 
indicate that Reck-mG cells in control cultures contain both mural (ca. 70%; Fig. 3d, bar 9) and endothelial 
(ca. 30%; Fig. 3e, bar 9) populations.
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Effects of Reck on the number and behaviors of Reck-mG cells. Reck-deficiency had multiple 
effects on Reck-mG cells. First, the number of Reck-mG cells surrounding an aortic ring was increased (Fig. 4a) 
whilst Ki67-staining revealed increased proliferation of both microvessel-associated and non-associated cells 
(Supplementary Fig. S5b and c, magenta). Second, the proportion of mural Reck-mG cells was decreased (Fig. 3d, 
bars 6, 12) whereas that of Reck-mG-negative endothelial cells was increased (Fig. 3e, bar 4). Third, endothelial 
Reck-mG cells were seldom found at microvessel tips in Reck cKO samples (Fig. 3b-12 and Supplementary Fig. 
S6-12, arrowheads; Supplementary Fig. S5d). Fourth, tight association of Reck-mG cells with microvessel stalks was 
somehow impaired (Figs. 4b-3 and -4; Fig. 4c, d); consistent to this finding in vitro, large aortae were frequently 
surrounded partially and unevenly by α SMA-positive mural cells that are not so tightly associated with a vessel 
as the control (Figs 4e-1) in sections of Reck−/− embryos at E10.5 (Figs 4e-2). Partial and uneven coverage of 
large aortae by α SMA-positive cells was also found in Reck cKO (Sm) embryos at E10.5 (Fig. 4f, g), suggesting a 
cell-autonomous function of Reck manifested in this phenotype. In addition, the irregularly spaced small vessels 
Figure 1. Cell type-selective inactivation of Reck in vivo using Sm22-Cre or Tie2-Cre mice. (a) Reck alleles 
used in this study. (b) Cells that expressed Reck (1), Sm22 (2, mural cells), or Tie2 (3, endothelial cells) emitted 
green fluorescence in the yolk sac of E10.5 embryos. For Reck, a pregnant mouse was injected with tamoxifen at 
8.5 dpc. Arrowhead indicates a cell with ambiguous morphology. (c) Viability of global Reck KO mice (Reck−/−, 
filled circles with solid line) or tissue-selective Reck knockouts, Reck cKO (Sm) [ReckE1fx/∆; Sm22-Cre, triangles] 
or Reck cKO (Tie) [ReckE1fx/∆; Tie2-Cre, square]. Expected frequency was 25% in all cases. (d) Morphology of 
control (ReckE1fx/∆) and Reck cKO (Sm) mice at E10.5. Whole embryo (panels 1, 4) and the dorsal, peri-neural 
area of serial sagittal sections, immunostained for CD31 (panels 2, 5) or α SMA (panels 3, 6), are shown. Brown 
signals indicate immunoreactivity. Arrow indicates an abnormal peri-neural vessel. Arrowheads highlight 
CD31-positive small vessels within the neural tube. (e) Distribution of α SMA-immunoreactivity in the sagittal 
sections of control, Reck cKO (Sm), and Reck KO mice at E10.5. Whole section (top row), caudal area containing 
a cross-sectional view of the neural tube and dorsal aorta (second row), and the heart (third row) are shown. 
Arrowheads show broken sites in panels 7, 8 and missing pericardial membrane in panels 6, 9. Asterisks 
highlight dorsal aorta. (f) Gross morphology of the control (ReckE1fx/∆) and Reck cKO (Tie) mice at E14.5. Arrow 
indicates intra-cranial hemorrhage. (g) Brain morphology in sections of control (upper panels) or Reck cKO 
(Tie) mice (lower panels) at E14.5 (panels 1, 2, 6, 7) or E18.5 (3–5, 8–10) that were subjected to hematoxylin 
and eosin (panels 1–3, 6–8), anti-laminin (panels 4, 9), or Kluver-Barrera (panels 5, 10) staining. Arrowheads 
indicate intra-cranial hemorrhage. Scale bar: (b) 20 μ m; (d) 1 mm (1, 4), 50 μ m (other panels); (e) 1 mm (1, 4, 7), 
100 μ m (2, 5, 8), 200 μ m (3, 6, 9); (f) 1 mm; (g) 1 mm (1, 2, 6, 7), 200 μ m (3, 8), 100 μ m (4, 9), 50 μ m (5, 10).
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(CD31-positive) in the neural tube of Reck cKO (Sm) mice were seldom accompanied by α SMA-positive mural 
cells (Figs 1d-5 and 6). Taken together, these findings suggest that Reck is required to achieve adequate compositions 
of, and interactions between, vessel-forming cells.
Functional relationship between Reck and FN in microvessel formation. FN and its receptor are 
known to be protected by RECK18,34,35. In ARA with Reck-positive cells, abundant FN fibrils could be visualized 
by immunofluorescent staining (Fig. 5a, panel 3 and 7), and prominent signals were found in the areas where 
mural (Sm22-mG) cells tightly associated with microvessels (Fig. 5a, panels 1–4, arrows). Near the tips of these 
microvessels, localized loss of FN fibrils were found near microvessel tips (Fig. 5a, panel 5–8, arrow). In Reck 
cKO cultures, signals for both FN (Fig. 5a-11) and laminin α 5 (Lama5), a component of vBM (Fig. 5b-5), were 
dampened and diffuse. When Reck cKO aortic rings were embedded in collagen gel supplemented with purified 
FN (Fig. 5c), some Reck cKO phenotypes, such as increased number, width, and aggregation of microvessels, 
increased area covered by microvessels, and decreased lacunarity of vascular network, were significantly suppressed 
(Fig. 5c-g) with increased perivascular FN- and Lama5-immunoreactivity (Supplementary Fig. S7a and b). Other 
Reck cKO phenotypes, such as peri-aortic halo and poor association of Reck-mG cells with microvessels, were not 
fully suppressed by FN supplementation (Fig. 5h, i). Hence, some Reck cKO phenotypes in ARA, such as excessive 
sprouting and destabilized microvessels, may be attributable to the reduced ambient FN in the absence of Reck.
Discussion
In this study, the importance of Reck in both mural and endothelial cells was documented in vivo and in vitro. 
Although selective inactivation of Reck in mural cells in vivo resulted in mid-gestation lethality and vascular 
defects reminiscent of Reck-null mice (Fig. 1c–e and ref. 2), Reck-inactivation in Tie2-positive cells also resulted 
in embryonic death, albeit at later stages with major impacts in the brain (Fig. 1c, f,g). In vitro, Reck-positive cells 
contribute to both mural and endothelial lineages (Fig. 3) whilst Reck-inactivation results in increased sprouting, 
decreased microvessel stability (Fig. 2) and altered composition (Fig. 3d–f) alongside a change in behavior that 
includes defective localization and reduced association (Figs 3b,4; Supplementary Fig. S5d) of vascular cells whose 
normal counterparts express Reck.
Figure 2. Effects of Reck-deficiency on microvessel formation in ARA. (a) Time course of microvessel 
formation (number per ring). Aortic rings from 5-weeks old control (Reck+/CrER; mTmG, blue line, n = 9) or Reck 
cKO (ReckE1fx/CrER; mTmG, red line, n = 4) mice were subjected to ARA (no medium change), and the number 
of microvessels was counted every other day from day 2 to 14. (b) Fluorescent micrographs of a control (panels 
1–5) or Reck cKO (panels 6–10) ring after incubation for indicated period of time in ARA without medium 
changes. Arrow indicates peri-aortic halo, and arrowheads highlight aggregating microvessels. Scale bar: 1 mm 
(5, 10), 0.5 mm (other panels). (c) Relative width of microvessels measured using ImageJ on high magnification 
images. Summary of 6 independent experiments (n = 36 rings for Cont and 30 rings for Reck cKO in total). 
(d, e) Parameters measured using AngioTool44. Summary of 8 independent experiments for Cont (46 rings) 
and 7 experiments for Reck cKO (43 rings). (f) Frequency of rings exhibiting peri-aortic halo. Summary of 6 
independent experiments for Cont (78 rings) and 3 independent experiments for Reck cKO (30 rings).
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Senger, Stratman, and Davis have proposed that mural-endothelial interaction triggers perivascular 
FN-deposition and subsequent vBM-deposition required for vascular stability in vivo 8,9. Our data in vitro sug-
gest that Reck plays a key role in this process by protecting FN from degradation (Supplementary Fig. S7c). The 
failure of FN to fully normalize the association of Reck-mG cells to the microvessels (Fig. 5i) fits with this model, 
(Supplementary Fig.S7c) which places the mural-endothelial interaction upstream of FN-deposition; raising a 
new question as to how Reck promotes this upstream event. Attenuated PDGF-receptor immunoreactivity found 
in Reck-deficient cells (Supplementary Fig. S8a and b) may be suggestive of its involvement in this failure, since 
PDGF is known to play a key role in pericyte-recruitment by endothelial cells 36 (Supplementary Fig. S8d-1).
The mechanism underlying the contribution of Reck-deficiency to the mislocalization of Reck-mG tip cells is 
presently unclear but several hypotheses can be envisaged. In Reck cKO culture, Flk1 signals were dampened and 
scarce in cells at the microvessel tips (Supplementary Fig. S5d, magenta), suggesting abortive tip-stalk specifica-
tion. Reck-deficient mice exhibit precocious neuronal differentiation, and this has been explained by attenuated 
Notch-signaling in neural precursor cells, due to de-regulated Adam10 that clips off Notch-ligands from adjacent 
cells16. In the vascular system, Notch signaling is known to suppress the tip cell phenotype and to promote acqui-
sition of the stalk cell phenotype6. Hence, an obvious model is that attenuated Notch-signaling in this system leads 
to ectopic expression of tip cell phenotype, which can explain the excessive sprouting found in Reck cKO rings in 
ARA. This model, however, predicts upregulation and/or ectopic expression of tip-cell markers (such as Flk1), but 
Figure 3. Identity and behavior of Reck-mG cells in ARA. (a) Morphology and microvessel-association of 
Reck-mG (1), Tie2-mG (2), and Sm22-mG (3) cells (green) in ARA at day 8. (b) Effects of Reck-deficiency on 
the nature of, and relationship between, Reck-mG, endothelial, and mural cells. Aortic rings from the control 
(Reck+/CrER; mTmG) or Reck cKO (ReckE1fx/CrER; mTmG) mice were subjected to ARA and immunostained for 
α SMA (magenta in panels 1, 3, 4, 6) or CD31 (magenta in panels 7, 9, 10, 12) at day 11. Green signals represent 
Reck-mG cells. Reck-mG/α SMA double positive staining could be observed at microvessel stalks from control 
mice (white stain, arrow, panel 3). In control cultures, Reck-mG/CD31 double positive staining could be 
observed at microvessel tips (white stain, arrowheads, panel 9) and Reck-mG single positive staining found at 
microvessel stalks (green stain, panel 9). This was lost in Reck cKO mice as observed by the lack of Reck-mG/
CD31 double positive at the microvessel tips (arrowheads, panel 12). (c) Flk1 immunoreactivity in a control 
microvessel. The control culture as in (b) was immunostained for a vascular tip-cell marker, Flk1/Vegfr2 
(magenta in panel 2 and 4). (d) Frequency of various cells in Reck-mG/α SMA double labeling experiments as 
shown in (b), panels 1–6. (e)Frequency of various cells in Reck-mG/CD31 double labeling experiments as shown 
in (b), panels 7–12. N = total nuclei, R = Reck-mG, S = α SMA, C= CD31, “+ ” means “-positive”. Number of 
images analyzed: (d) Cont (n = 17), Reck cKO (n = 12). (e) Cont (n = 6), Reck cKO (n = 9). Bars 1–8 represent 
proportion among all cells. Bars 9 and10 represent proportion among Reck-mG cells. Bars 11 and 12 represent 
proportion among α SMA-positive cells (d) or CD31-positive cells (e). Aortic rings were prepared from at least 3 
animals per group. Scale bar: (a, b) 100 μ m, (c) 20 μ m.
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this was not the observed (Supplementary Fig. S5d). An alternative model involves direct Flk1-downregulation, 
for instance, by proteolytic cleavage that may scramble tip-stalk specification (Supplementary Fig. S8d-2). Another 
potential model is binding between VEGF and FN37 that somehow contributes to tip-stalk association or speci-
fication (Supplementary Fig. S8d-3), which fits with our finding that FN may suppress the mislocalization of tip 
cells found in Reck cKO samples to some extent (Supplementary Fig. S8c; Fig. 5i).
Likewise, multiple models can be proposed to explain the increased cell proliferation found in Reck cKO cul-
tures. Since Notch-signaling is known to confer quiescence to the vessels6, reduced Notch-ligands may promote 
cell proliferation. Alternatively, as observed in colon cancer cells38, Reck-deficiency may promote cell cycle pro-
gression by upregulating Skp2, thereby downregulating the Cdk inhibitor p27. These issues need to be addressed 
in future studies.
We have previously speculated that dilated vessels found in Reck-deficient mice may result from impaired 
non-sprouting angiogenesis (i.e., intussusception)27. The present data, however, support an alternative model 
that dilated vessels could result from aggregation and lateral fusion of excessive, unstable microvessels (Fig. 5j-4). 
Our data also raise the interesting possibility that Reck may serve as a key regulator of vascular morphogenesis 
Figure 4. Effects of Reck on vessel-association of Reck-mG cells in ARA and mural cells in vivo. (a) Time 
course for the number of Reck-mG cells in ARA. Aortic rings from the 5-weeks-old control (n = 10) or Reck 
cKO (n = 7) mice were subjected to ARA and all Reck-mG cells surrounding each ring (irrespective or their 
association with microvessels) were counted from day 6 to 14. (b) Distribution and morphology of Reck-mG 
cells (green) at day 7 and 14 in ARA. In control cultures, Reck-mG cells are tightly associated with microvessel 
stalks (arrows in panel 1 and 2) but this is impaired in Reck cKO (panel 3 and 4). (c) Frequency of Reck-mG 
cells tightly associated with microvessels at day 8. n = 3. (d) Frequency of microvessels with tightly associated 
Reck-mG cells at day 8. n = 3. (e–g) Effect of Reck-deficiency on the distribution of mural cells in vivo. (e) 
Sagittal section of wild type (Cont) or Reck−/− (Reck KO) mouse embryos at E10.5 immunostained for α SMA 
(brown). Micrographs focusing on large aorta are shown. (f,g) Sagittal sections of ReckE1fx/∆ mice (control; 
panels 1, 2) and Reck cKO (Sm) mice (panels 3, 4) at E10.5. Adjacent sections were immunostained for CD31 
(with Hematoxylin counter-stain; panels 1, 3) and for α SMA (panels 2, 4), respectively. Micrographs focusing 
on large aortas in the middle (f) and caudal (g) part of the body are shown. In (e–g), arrowhead indicates an 
area of vessel wall abundant in mural cells, and arrow highlights an area where the mural cell layer is very thin 
or absent. Scale bar: (b) 200 μ m (panel 2) and 50 μ m (other panels), (e) 100 μ m, (f) 50 μ m, (g) 100 μ m.
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Figure 5. Functional relationship between Reck and FN in microvessel formation in ARA. (a) Effects of Reck-
deficiency on FN fibrils in ARA. Aortic rings from control 1 (Reck+/+; Sm22-Cre; mTmG), control 2 (Reck+/CrER; 
mTmG), and Reck cKO (ReckE1fx/CrER; mTmG) mice pretreated with tamoxifen were subjected to ARA and stained for 
FN (magenta, panels 3, 4, 7, 8, 11, 12) at day 10. Note that in the control samples, FN (magenta) signals are abundant 
around the extending sprouts (panels 3, 7), particularly accumulated in the areas where mT (red) and Sm22 (green) 
signals overlap (arrows in panels 1–4), but sparse near the tip of the sprouts (arrow in panels 5–8). Paucity of FN 
(magenta) signals in Reck cKO sample (panels 9–12) could also be observed. (b) Similar cultures stained for laminin 
α 5 (Lama5, turquoise). (c–i) Effects of exogenous FN on the phenotype of Reck cKO microvessels in ARA. ARAs 
were performed without or with addition of FN (1 μ g/ml) in the gel. (c) Typical morphology of microvessels from 
Reck cKO aortic rings after incubation for 9 days in the absence (1) or presence (2) of exogenous FN. (d–i) Indicated 
parameters were measured as described in Fig. 2 a, c-f (d–h) and Fig. 4d (i) using micrographs (as shown in c) taken 
at day 10. Cont: n ≥ 14 rings (3 aortae); Reck cKO: n ≥ 43 rings (6 aortae). (j) A model consistent with our findings 
in vitro. When Reck is present (panels 1, 3), endothelial sprouting led by tip cells (blue) is appropriately regulated; 
tight association of mural cells (green) with endothelial tubules (orange) is promoted; and individual vessels are 
stabilised. When Reck is absent or reduced (panels 2, 4), endothelial sprouting and collagenolysis are activated; tip 
cells and mural cells localise inappropriately; and microvessels destabilise, permitting lateral fusion and ectopic 
anastomoses. Scale bar: (a) 20 μ m in panels 5–8, 100 μ m in others; (b) 50 μ m; (c) 1 mm.
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by regulating the number and size of the vessels, the area covered by the vessels, as well as the site and timing of 
anastomoses (Fig. 5j). We also speculate that RECK-dysfunction may underlie various conditions that give rise 
to fragile, leaky blood vessels, such as cancers39 and RASopathies40, since several activated oncogenes, including 
mutated RAS, strongly suppress RECK expression12,41. Compounds capable of upregulating endogenous RECK42 
may be useful in ameliorating such conditions.
Methods
Mice. Animal experiments were approved by Animal Experimentation Committee, Kyoto University and 
conducted in accordance with its regulation. Generation and genotyping of mice carrying the ReckCrER (also 
known as Reck-CreERT2 or KI), ReckE1fx (also known as R1), Reck∆, or ReckLow (also known as R2neo) allele has 
been described elsewhere21. To evaluate the roles of Reck in mural cells, Reck+/∆ mice were crossed with mice 
carrying Sm22-Cre transgene30 to obtain Reck+/∆; Sm22-Cre male mice, which were then crossed with ReckE1fx/E1fx 
female mice, and their pups harvested at various stages for genotyping and morphological studies. To evaluate 
the roles of Reck in endothelial cells, Reck+/∆ mice were crossed with Tie2-Cre transgenic mice31 to obtain Reck+/∆; 
Tie2-Cre male mice, which were crossed with ReckE1fx/E1fx female mice, and their pups examined at various stages. 
To visualise cells expressing Tie2, Sm22, or Reck, female mice homozygous for the allele containing the mTmG 
transgene32 were crossed with male mice carrying the Tie2-Cre, Sm22-Cre, or ReckCrER transgene to obtain pups 
carrying both the mTmG and Cre transgenes. To test the roles of Reck in microvessel formation in vitro, Reck+/CrER; 
mTmG/mTmG male mice were crossed with ReckE1fx/E1fx female mice (both in ICR background), and ReckE1fx/CrER; 
mTmG mice (Reck cKO) were selected. To generate a matched control, Reck+/CrER male mice were crossed with 
mTmG/mTmG female mice, and Reck+/CrER; mTmG mice (Cont) were selected. Mice carrying the ReckCrER trans-
gene were treated four times by daily intra-peritoneal injections of tamoxifen (80 mg/kg), and then two days later, 
aortae were harvested for ARA.
Histology. Mouse embryos were fixed, sliced (10 μ m-thick), and stained with Hematoxylin and Eosin21, by 
immunohistochemistry with anti-CD31, anti-α SMA, or anti-laminin27, or by Kluver-Barrera method43 as described 
previously. Tissues from mice carrying the mTmG reporter were fixed, incubated overnight in 30% sucrose, embed-
ded in O.C.T, frozen at –80 oC, sliced (5μ m-thick), and observed with a fluorescent microscope.
Aortic ring assay. ARA was performed following the protocol of Baker et al.29 with some modifications. The 
following conditions, optimised as shown in Supplementary Fig. S2, were used unless otherwise stated. Thoracic 
aortae were dissected from 5-week old transgenic mice after overnight starvation. The peri-aortic fibroadipose 
tissue and blood were carefully removed with fine microdissecting forceps, and aorta tunics were preserved with-
out damage. After cleaning, aortae were cut into 1 mm-thick rings, rinsed 3 times with PBS (− ), and incubated 
overnight in Opti-MEM at 37 °C. The rings were then embedded in a mound of gel prepared on ice by mixing 5 
volumes of 3 mg/ml collagen type I-A (Nitta Gelatin, Osaka, Japan), 3 volumes of 3 mg/ml collagen type IV (Nitta 
Gelatin, Osaka, Japan), 1 volume of 10× DMEM, and 1 volume of reconstitution buffer (2.2 g NaHCO3 in 100 ml 
of 0.05 N NaOH and 200 mM HEPES). For embedding, 50 μ l of the collagen mixture was placed into wells of 
96-well plates and incubated at 37 °C for 10 minutes to form a basal gel. Aortic rings were placed on the basal gel 
and covered with 10 μ l of cold collagen mixture. After 20-min incubation at 37 °C, each well was fed with 200 μ l 
Opti-MEM (Invitrogen) supplemented with 20 ng/ml VEGFa (R&D systems), 5% fetal horse serum (Cell Culture 
Laboratories, Ohio, USA), 100 U/ml penicillin and 100 μ g/ml streptomycin. The dishes were tightly sealed with 
parafilm, kept at 37 °C for two weeks, and examined every day under an inverted microscope. Micrographs were 
taken every day up to day 14 for morphometric analyses. In some experiments (Fig. 5c–i; Supplementary Fig. S7, 
S8c), bovine plasma fibronectin (Sigma, F1141) was added to the gel at 1 μ g/ml.
Morphometry. Microscopic images were recorded with a digital camera at various time points and magnifica-
tion, depending on the properties to be assessed: x40 on day 3 to 7 for microvessel growth (number and length), x100 
on day 8 and 9 for microvessel width, and x200 on day 10 to 14 for the cells associated with microvessels. The images 
were analysed using ImageJ to determine the length, width, and anastomosis of microvessels and the area covered 
by them. The numbers of microvessels were counted manually, following the criteria described by Aplin et al.33, 
where outgrowth constituted by singular cells such as fibroblasts, pericytes, and macrophages or segmented sprout 
structures were not included. AngioTool44 was also employed to quantify microvessel area, branching points (total 
junctions), total length, end points, and lacunarity.
Immunofluorescent staining. Aortic rings extending microvessels were fixed with 4% formalin, perme-
abilised with 0.25% Triton-X for 15 min and incubated in PBS (+ ) containing 10% goat serum for 1 h at room 
temperature to block non-specific binding.After being rinsed with PBS (+ ) for 5 min they were then incu-
bated overnight with primary antibody diluted in PBLEC29. After rinsing with PBS (+ ) (3 × 10 min), samples 
were then incubated for 30 min at 37 °C in a cocktail of Alexa Fluor (488, 555, or Cy5) conjugated with appro-
priate secondary antibodies in PBLEC. Samples were rinsed then incubated (1 min) with Hoechst33342 and 
mounted using Fluoromount (Diagnostic BioSystems). Images were recorded using a fluorescence microscope 
(OlympusX70 or Keyence BZ-9000). The following primary antibodies were used: laminin (Progen 10765), 
CD31 (BD Pharmingen 550274), Reck [RECK-F, polyclonal rabbit antibodies (Matsuzaki et al., in prepara-
tion) and 5B11D1212]; α -Sma (DAKO MO85), fibronectin (BD Biosciences, 610078), PDGFR-beta (Santa Cruz 
Biotechnology sc-432), Flk-1 (Santa Cruz Biotechnology sc-625), LAMA5 (Sigma-Aldrich SAB4501720) and 
Ki67 (Leica Biosystems NCL-Ki67p).
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Statistics. Quantitative data are presented in the form of mean ± sem in graphs. Significance of difference 
between two sets of data were assessed by Student’s t-test using the TTEST function in Excel (Microsoft), and the 
results are presented by symbols: *P < 0.05, **P < 0.01.
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